Ignacio I. Wistuba

发表

Abstract 2413: Cell type-specific deconvolution of heterogeneous tumor samples with immune infiltration using expression data

Christopher Holmes, Jaeil Ahn, Zeya Wang, 2016 .

Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune Infiltration

Wei Lu, Jeffrey S. Morris, Bo Li, 2017, bioRxiv.

Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues

Mei Jiang, Jaime Rodriguez-Canales, Ignacio I. Wistuba, 2017, Scientific Reports.

Liquid Biopsy for Advanced Non‐Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

Paul Baas, Ignacio I. Wistuba, Robert Pirker, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

miR-337-3p and Its Targets STAT3 and RAP1A Modulate Taxane Sensitivity in Non-Small Cell Lung Cancers

John D. Minna, Alexander Pertsemlidis, Ignacio I. Wistuba, 2012, PloS one.

Divergent Genomic and Epigenomic Landscapes of Lung Cancer Subtypes Underscore the Selection of Different Oncogenic Pathways during Tumor Development

John D. Minna, John Yee, Raj Chari, 2011, PloS one.

Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents

Michael A. Davies, Gordon B. Mills, John M. Mariadason, 2012, Clinical Cancer Research.

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.

William Pao, John D. Minna, Yu Shyr, 2014, JAMA.

Essential Role of Aldehyde Dehydrogenase 1A3 for the Maintenance of Non–Small Cell Lung Cancer Stem Cells Is Associated with the STAT3 Pathway

John D. Minna, Jaime Rodriguez-Canales, Chunli Shao, 2014, Clinical Cancer Research.

Effect of neoadjuvant chemotherapy on the immune microenvironment in non–small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches

Boris Sepesi, Ignacio I. Wistuba, John V. Heymach, 2018, Journal of Immunotherapy for Cancer.

Intra-tumor Heterogeneity in Localized Lung Adenocarcinomas Delineated by Multi-region Sequencing

Yuanqing Ye, Harshad Mahadeshwar, David C. Wedge, 2015 .

Map2k4 Functions as a Tumor Suppressor in Lung Adenocarcinoma and Inhibits Tumor Cell Invasion by Decreasing Peroxisome Proliferator-Activated Receptor γ2 Expression

Yanan Yang, Young-Ho Ahn, Elizabeth J. Goldsmith, 2011, Molecular and Cellular Biology.

Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells

Calum MacAulay, John D. Minna, David S. Shames, 2009, PloS one.

miR-93, miR-98, and miR-197 Regulate Expression of Tumor Suppressor Gene FUS1

John D. Minna, Alexander Pertsemlidis, Lin Ji, 2009, Molecular Cancer Research.

Sex Determining Region Y-Box 2 (SOX2) Is a Potential Cell-Lineage Gene Highly Expressed in the Pathogenesis of Squamous Cell Carcinomas of the Lung

John D. Minna, Humam Kadara, Yang Xie, 2010, PloS one.

Nuclear Receptor Expression Defines a Set of Prognostic Biomarkers for Lung Cancer

John D. Minna, Guanghua Xiao, Yang Xie, 2010, PLoS medicine.

Dynamic changes during the treatment of pancreatic cancer

Louis Scampavia, Arnold J. Levine, Ignacio I. Wistuba, 2018, Oncotarget.

Methodological and practical challenges for personalized cancer therapies

Juri G. Gelovani, Ignacio I. Wistuba, Roy S. Herbst, 2011, Nature Reviews Clinical Oncology.

Multiplatform-based Molecular Subtypes of Non-Small Cell Lung Cancer

Yiling Lu, Rehan Akbani, Gordon B. Mills, 2016, Oncogene.

Frequent Coamplification and Cooperation between C-MYC and PVT1 Oncogenes Promote Malignant Pleural Mesothelioma

David C. Rice, Ignacio I. Wistuba, Barbara Mino, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Expression Signatures of Metastatic Capacity in a Genetic Mouse Model of Lung Adenocarcinoma

Dror Berel, Yanan Yang, Ignacio I. Wistuba, 2009, PloS one.

Human Lung Epithelial Cells Progressed to Malignancy through Specific Oncogenic Manipulations

John D. Minna, David S. Shames, Yang Xie, 2013, Molecular Cancer Research.

The Role of PKR / eIF 2 a Signaling Pathway in Prognosis of Non-Small Cell Lung Cancer

Behrens, Ignacio I. Wistuba, Liping Yu, 2011 .

Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

Yu Cao, Yuanqing Ye, Harshad Mahadeshwar, 2014, Science.

Nuclear factor‐κB (nf‐κB) is frequently expressed in lung cancer and preneoplastic lesions

Bharat B. Aggarwal, Ignacio I. Wistuba, Shishir Shishodia, 2006 .

Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer

Lawrence H. Schwartz, Donald A. Berry, Janis M. Taube, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Intratumoral Epiregulin Is a Marker of Advanced Disease in Non–Small Cell Lung Cancer Patients and Confers Invasive Properties on EGFR-Mutant Cells

Jie Zhang, Ignacio I. Wistuba, Wei Wei, 2008, Cancer Prevention Research.

Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer

Boris Sepesi, Joe Y. Chang, Laurence Court, 2018, Scientific Reports.

Abstract LB-318: Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE study): Reproducibility assessment of an automated multiplexed immunofluorescence slide staining, imaging, and analysis workflow

Mei Jiang, Janis M. Taube, Yi Zheng, 2019, Tumor Biology.

Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients

Jaime Rodriguez-Canales, Humam Kadara, Boris Sepesi, 2016, Clinical Cancer Research.

An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Michael Peyton, John D. Minna, Li Shen, 2012, Clinical Cancer Research.

Collagen XXIII: A Potential Biomarker for the Detection of Primary and Recurrent Non–Small Cell Lung Cancer

Ignacio I. Wistuba, Henry A. Feldman, Scott J. Rodig, 2010, Cancer Epidemiology, Biomarkers & Prevention.